IL-2 Clinical Development: Lessons Learned – But Possibly Forgotten

Time: 8:00 am
day: Pre-Event Content
stream: Stream one


  • Explore how HD-IL-2 is critical for durable CRs
  • Assess how dissociation of toxicity from efficacy is difficult with systemic administration
  • Review why activity persists after PD-1 blockade
  • Examine modified IL-2 as a work in progress